The Hepatitis C Cure that Costs $4 in India, But Will Cost You $1000 in the U.S.
Another monopoly for the pharmaceutical industry has been created after the Federal Food and Drug Administration (FDA) approved Gilead Science’s Sovaldi for the patent of a new breakthrough drug. The drug, which costs around...